Evidence map›Paper›PMID 20602231›Full record

ArticleCancer immunology, immunotherapy : CII2010

Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.

Jessica C Shand, Johan Jansson, Yu-Chiao Hsu, Andrew Campbell, Craig A Mullen

Abstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica C ShandDivision of Pediatric Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Johan Jansson
Yu-Chiao Hsu
Andrew Campbell
Craig A Mullen

Funding

NCI NIH HHS 1R01CA10628
6 · The paper itself

Abstract

The effectiveness of allogeneic graft-versus-leukemia (GVL) activity in control of acute lymphoblastic leukemia is generally regarded as poor. One possible factor is dynamic adaptation of the leukemia cell to the allogeneic environment. This work tested the hypothesis that the pattern of gene expression in acute lymphoblastic leukemia cells in an allogeneic environment would differ from that in a non-allogeneic environment. Expression microarray studies were performed in murine B lineage acute lymphoblastic leukemia cells recovered from mice that had undergone allogeneic MHC-matched but minor histocompatibility antigen mismatched transplants. A limited number of genes were found to be differentially expressed in ALL cells surviving in the allogeneic environment. Functional analysis demonstrated that genes related to immune processes, antigen presentation, ubiquitination and GTPase function were significantly enriched. Several genes with known immune activities potentially relevant to leukemia survival (Ly6a/Sca-1, TRAIL and H2-T23) were examined in independent validation experiments. Increased expression in vivo in allogeneic hosts was observed, and could be mimicked in vitro with soluble supernatants of mixed lymphocyte reactions or interferon-gamma. The changes in gene expression were reversible when the leukemia cells were removed from the allogeneic environment. These findings suggest that acute lymphoblastic leukemia cells respond to cytokines present after allogeneic transplantation and that these changes may reduce the effectiveness of GVL activity.

Indexed as

Bone Marrow TransplantationAnimalsBiomarkers, TumorBlotting, WesternDrug Delivery SystemsGene Expression ProfilingGraft SurvivalGraft vs Leukemia EffectInterferon-gammaMiceMice, Inbred C57BLMinor Histocompatibility AntigensOligonucleotide Array Sequence AnalysisPrecursor B-Cell Lymphoblastic Leukemia-LymphomaReverse Transcriptase Polymerase Chain ReactionRNA, MessengerBiomarkers, TumorInterferon-gammaMinor Histocompatibility AntigensRNA, Messenger

Identifiers

PMID20602231
PMCPMC11030998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.